Business Context and Reporting Period
This Form 8-K is a current report filed by Fluidigm Corporation (noted as Standard BioTools Inc. in metadata) on August 9, 2011. The filing serves to report the company's financial results for the three and six months ended June 30, 2011, as detailed in a press release furnished as Exhibit 99.1.
Key Financial Metrics
The filing text itself does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being contained within the attached press release (Exhibit 99.1), which is not included in the provided source text.
Material Changes
The filing does not explicitly detail material changes versus prior periods within the body text. It solely references the issuance of the press release containing the comparative financial results.
Guidance, Outlook, and Risks
The filing does not provide specific guidance, outlook, management commentary, or risk factors in the text provided. It notes that the information furnished under Item 2.02 and the attached exhibit shall not be deemed "filed" for purposes of Section 18 of the Exchange Act or incorporated by reference, except as expressly set forth by specific reference.
Investor Verification Checklist
- Verify the specific revenue and net loss figures for the three and six months ended June 30, 2011, by reviewing the attached Exhibit 99.1 (Press Release).
- Confirm the company's cash position and liquidity status as reported in the press release.
- Review the press release for any updated forward-looking guidance or strategic initiatives mentioned by management.
- Note that the financial data in this 8-K is not incorporated by reference into other filings unless explicitly stated.